Taoyang Chen

Qidong Liver Cancer Prevention Research — China

Medicine · Health Sciences

42h-index5.2kcitations142works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(36), Liver Disease Diagnosis and Treatment(24), Hepatitis C virus research(22), RNA modifications and cancer(22), Cancer Cells and Metastasis(19)

Publications142 total

PPIL1 promotes hepatocellular carcinoma progression and associates with poor prognosis
Naunyn-Schmiedeberg s Archives of Pharmacology·2026
Erratum: MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
Hepatology·2025
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma
Cellular Oncology·2024· 3 cited
NR4A3 inhibits the tumor progression of hepatocellular carcinoma by inducing cell cycle G0/G1 phase arrest and upregulation of CDKN2AIP expression
International Journal of Biological Sciences·2024· 8 citedOpen Access
RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research·2023· 10 citedOpen Access
The stage-dependent prognostic role of ARID1A in hepatocellular carcinoma
Translational Cancer Research·2023· 5 citedOpen Access
Data from Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
2023Open Access
Supplementary Materials and Methods, Supplementary Tables 1 through 3, and Supplementary Figures 1 through 8 from Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
2023Open Access
Data from Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
2023Open Access
Supplementary Materials and Methods, Supplementary Tables 1 through 3, and Supplementary Figures 1 through 8 from Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
2023Open Access
Supplementary Data from A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
Data from A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
Data from A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Data from ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Jinjun Li(32), Ming Yao(28), Chao Ge(26), Fangyu Zhao(23), Hong Li(17), Xianghuo He(16), Hua Tian(15), Haiyang Xie(13), Jianren Gu(12), Yingjun Zhao(9), Shenglin Huang(8), Guo‐Ping Jiang(8), Qifeng Wang(8), Jie Ding(7), Chunfeng Qu(7), Linhui Liang(6), Mingxia Yan(6), Miaoxin Zhu(6), Jianhua Lu(6), Ruopeng Zha(6)